William E. Shomali

Hematology

965 High St
Palo Alto, CA 94301

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.

Journal: Experimental hematology & oncology

Published: June 21, 2026

A case of true acute eosinophilic leukemia arising from myelodysplastic syndrome.

A case of true acute eosinophilic leukemia arising from myelodysplastic syndrome.

Journal: Journal of hematopathology

Published: April 29, 2026

Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.

Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.

Journal: The Journal of allergy and clinical immunology

Published: December 16, 2025

Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement.

Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement.

Journal: NEJM evidence

Published: August 26, 2025

An adaptive survival prediction model in CMML.

An adaptive survival prediction model in CMML.

Journal: Blood

Published: August 14, 2025

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL.

Journal: Blood advances

Published: July 23, 2025

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Journal: Blood

Published: May 14, 2025

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Journal: Blood

Published: May 14, 2025

Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib.

Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib.

Journal: Blood neoplasia

Published: March 11, 2025

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 23, 2024

Real time machine learning prediction of next generation sequencing test results in live clinical settings.

Real time machine learning prediction of next generation sequencing test results in live clinical settings.

Journal: NPJ digital medicine

Published: February 12, 2024

Avapritinib versus Placebo in Indolent Systemic Mastocytosis.

Avapritinib versus Placebo in Indolent Systemic Mastocytosis.

Journal: NEJM evidence

Published: February 06, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026